Effects of Low-level Laser Therapy After Surgical Removal of Impacted Lower Third Molar
Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Feb 20, 2020
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
Goal: The aim of this study was to evaluate the effects of low-level laser (LLL) after surgical removal of impacted lower third molars (ILTM), including pain level, postoperative facial swelling, trismus and non-stimulated saliva secretory immunoglobulin A (sIgA).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • had two impacted lower third molars symmetrically in the same position as the classifications of Pell- Gregory and Winter diagnosed by 2D panoramic radiography
- Exclusion Criteria:
- • Patients with systemic diseases such as cardiovascular disease, hypertension, diabetes mellitus, pregnant, local infections
- • refused to participate in the study
- • patients who did not follow-up visit would be excluded
About University Of Medicine And Pharmacy At Ho Chi Minh City
The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, Dictrict 5, Vietnam
Ho Chi Minh City, , Vietnam
Patients applied
Trial Officials
Ly TB Nguyen, PhD
Study Director
University of Medicine and Pharmacy at Ho Chi Minh City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials